Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Li Liu

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Schizophrenia Research|April 5, 2007
No association evidence between schizophrenia and dystrobrevin-binding protein 1 (DTNBP1) in Taiwanese familiesChih-Min Liu, Yu-Li Liu, Cathy Shen-Jang Fann, et al.
Psychiatric Genetics|December 14, 2007
HTF9C gene of 22q11.21 region associates with schizophrenia having deficit-sustained attentionYu-Li Liu, Cathy Shen-Jang Fann, Chih-Min Liu, et al.
Journal of Clinical Psychopharmacology|February 15, 2014
The association of genetic polymorphisms in the κ-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenanceSheng-Chang Wang, Hsiao-Hui Tsou, Ren-Hua Chung, et al.
Journal of Clinical Psychopharmacology|January 5, 2013
PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolitesHui-Ju Tsai, Sheng-Chang Wang, Jia-Ni Tian, et al.
Pharmacogenomics|December 3, 2010
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetineKeh-Ming Lin, Hsiao-Hui Tsou, I-Ju Tsai, et al.
Plos One|March 18, 2016
Haplotypes of the D-Amino Acid Oxidase Gene Are Significantly Associated with Schizophrenia and Its Neurocognitive DeficitsYu-Li Liu, Sheng-Chang Wang, Hai-Gwo Hwu, et al.
Biological Psychiatry|September 26, 2006
A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: Association with impairment of sustained attentionYu-Li Liu, Cathy Shen-Jang Fann, Chih-Min Liu, et al.
Biological Psychiatry|June 24, 2008
RASD2, MYH9, and CACNG2 genes at chromosome 22q12 associated with the subgroup of schizophrenia with non-deficit in sustained attention and executive functionYu-Li Liu, Cathy Shen-Jang Fann, Chih-Min Liu, et al.
Pharmacogenomics|September 10, 2011
Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patientsChia-Hui Chen, Sheng-Chang Wang, Hsiao-Hui Tsou, et al.
Pharmacogenetics and Genomics|September 23, 2010
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatmentKeh-Ming Lin, Yen-Feng Chiu, I-Ju Tsai, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Schizophrenia Research|April 5, 2007
No association evidence between schizophrenia and dystrobrevin-binding protein 1 (DTNBP1) in Taiwanese familiesChih-Min Liu, Yu-Li Liu, Cathy Shen-Jang Fann, et al.
Psychiatric Genetics|December 14, 2007
HTF9C gene of 22q11.21 region associates with schizophrenia having deficit-sustained attentionYu-Li Liu, Cathy Shen-Jang Fann, Chih-Min Liu, et al.
Journal of Clinical Psychopharmacology|February 15, 2014
The association of genetic polymorphisms in the κ-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenanceSheng-Chang Wang, Hsiao-Hui Tsou, Ren-Hua Chung, et al.
Journal of Clinical Psychopharmacology|January 5, 2013
PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolitesHui-Ju Tsai, Sheng-Chang Wang, Jia-Ni Tian, et al.
Pharmacogenomics|December 3, 2010
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetineKeh-Ming Lin, Hsiao-Hui Tsou, I-Ju Tsai, et al.
Plos One|March 18, 2016
Haplotypes of the D-Amino Acid Oxidase Gene Are Significantly Associated with Schizophrenia and Its Neurocognitive DeficitsYu-Li Liu, Sheng-Chang Wang, Hai-Gwo Hwu, et al.
Biological Psychiatry|September 26, 2006
A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: Association with impairment of sustained attentionYu-Li Liu, Cathy Shen-Jang Fann, Chih-Min Liu, et al.
Biological Psychiatry|June 24, 2008
RASD2, MYH9, and CACNG2 genes at chromosome 22q12 associated with the subgroup of schizophrenia with non-deficit in sustained attention and executive functionYu-Li Liu, Cathy Shen-Jang Fann, Chih-Min Liu, et al.
Pharmacogenomics|September 10, 2011
Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patientsChia-Hui Chen, Sheng-Chang Wang, Hsiao-Hui Tsou, et al.
Pharmacogenetics and Genomics|September 23, 2010
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatmentKeh-Ming Lin, Yen-Feng Chiu, I-Ju Tsai, et al.
Pageof 14